Professor, Pediatric Hematology and Oncology, Baylor College of Medicine
Pediatric Hematology & Oncology
Dr. Stacey Berg, MD
|
|
Give Review
Stacey Berg is an expert in the field of Pediatric Hematology & Oncology. She researched medicine at University of Pittsburgh School of Medicine. She has 3 awards "America's Top Doctors", "Top Doctors:SE Texas" and "America's Top Doctors for Cancer". Stacey Berg is also a published physician. She has 101 publication published. The most recent publication is: Pharmacokinetics of O6-benzylguanine and its active metabolite 8-oxo-O6-benzylguanine in plasma and cerebrospinal fluid after intrathecal administration of O6-benzylgu...
Publications
- Pharmacokinetics and pharmacogenomics of daunorubicin in children: a report from the Children's Oncology Group.
- Pharmacokinetics of doxorubicin in pregnant women.
- Identification and Characterization of Separase Inhibitors (Sepins) for Cancer Therapy.
- A phase-1 pharmacokinetic optimal dosing study of intraventricular topotecan for children with neoplastic meningitis: a Pediatric Brain Tumor Consortium study.
- Pharmacokinetics of intrathecal gemcitabine in nonhuman primates.
- Systemic chemotherapy, intrathecal chemotherapy, and symptom management in the treatment of leptomeningeal metastasis.
- Plasma and cerebrospinal fluid pharmacokinetic study of BNP1350 in nonhuman primates.
- Plasma and cerebrospinal fluid pharmacokinetics of depsipeptide (FR901228) in nonhuman primates.
- Plasma and cerebrospinal fluid pharmacokinetics of imatinib after administration to nonhuman primates.
- Plasma and cerebrospinal fluid pharmacokinetics of rebeccamycin (NSC 655649) in nonhuman primates.
- Phase I and pharmacokinetic study of thalidomide with carboplatin in children with cancer.
- Phase I study of the proteasome inhibitor bortezomib in pediatric patients with refractory solid tumors: a Children's Oncology Group study (ADVL0015).
- Phase I trial and pharmacokinetic study of raltitrexed in children with recurrent or refractory leukemia: a pediatric oncology group study.
- Phase II study of nelarabine (compound 506U78) in children and young adults with refractory T-cell malignancies: a report from the Children''s Oncology Group.
- Plasma and cerebrospinal fluid pharmacokinetics of clofarabine in nonhuman primates.
- Current treatment of leptomeningeal metastases: systemic chemotherapy, intrathecal chemotherapy and symptom management.
- Bortezomib interactions with chemotherapy agents in acute leukemia in vitro.
- Plasma and cerebrospinal fluid pharmacokinetics of nelarabine in nonhuman primates.
- Methotrexate pharmacokinetics in infants with acute lymphoblastic leukemia.
- Plasma and cerebrospinal fluid pharmacokinetics of valproic acid after oral administration in non-human primates.
- Synergy of karenitecin and mafosfamide in pediatric leukemia, medulloblastoma, and neuroblastoma cell lines.
- Phase I clinical trial of intrathecal gemcitabine in patients with neoplastic meningitis.
- Phase 1 trial of O6-benzylguanine and BCNU in children with CNS tumors: a Children''s Oncology Group study.
- Phase I pharmacokinetic and pharmacodynamic study of temozolomide in pediatric patients with refractory or recurrent leukemia: a Children''s Oncology Group Study.
- Ethical challenges in cancer research in children.
- Characteristics and outcome of pediatric patients enrolled in phase I oncology trials.
- Impact of body composition on pharmacokinetics of doxorubicin in children: a Glaser Pediatric Research Network study.
- Plasma and cerebrospinal fluid pharmacokinetics of tasidotin (ILX-651) and its metabolites in non-human primates.
- When too much is just enough: what do oncologists tell parents?
- Please don't call my mom: pediatric consent and confidentiality.
- Poly(ADP-ribose) polymerase inhibitor ABT-888 potentiates the cytotoxic activity of temozolomide in leukemia cells: influence of mismatch repair status and O6-methylgu...
- Reasons for participation in optional pharmacokinetic studies in children with cancer: a Children's Oncology Group phase 1 consortium study.
- Safety, pharmacokinetics, and immunomodulatory effects of lenalidomide in children and adolescents with relapsed/refractory solid tumors or myelodysplastic syndrome: a...
- Educational paper. The development of new therapies for pediatric oncology.
- A phase II study of O6-benzylguanine and temozolomide in pediatric patients with recurrent or progressive high-grade gliomas and brainstem gliomas: a Pediatric Brain T...
- A phase I study of irinotecan administered on a weekly schedule in pediatric patients.
- Intrathecal mafosfamide: a preclinical pharmacology and phase I trial.
- Pharmacokinetics of O(6)-benzylguanine in pediatric patients with central nervous system tumors: a pediatric oncology group study.
- Phase I clinical trial of intrathecal topotecan in patients with neoplastic meningitis.
- Pharmacokinetics of phenylacetate administered as a 30-min infusion in children with refractory cancer.
- Plasma and cerebrospinal fluid pharmacokinetics of SU5416 after intravenous administration in nonhuman primates.
- Pharmacokinetics and cerebrospinal fluid penetration of phenylacetate and phenylbutyrate in the nonhuman primate.
- Phase II trial of topotecan administered as 72-hour continuous infusion in children with refractory solid tumors: a collaborative Pediatric Branch, National Cancer Ins...
- Pharmacokinetics of O6-benzylguanine and its active metabolite 8-oxo-O6-benzylguanine in plasma and cerebrospinal fluid after intrathecal administration of O6-benzylgu...
- A phase I study of irinotecan in pediatric patients: a pediatric oncology group study.
- Phase I/II trial and pharmacokinetics of intrathecal diaziquone in refractory meningeal malignancies.
- Pharmacokinetics of PEG-L-asparaginase and plasma and cerebrospinal fluid L-asparagine concentrations in the rhesus monkey.
- Phase I trial of docetaxel administered as a 1-hour infusion in children with refractory solid tumors: a collaborative pediatric branch, National Cancer Institute and ...
- Phase I trial and pharmacokinetic study of all-trans-retinoic acid administered on an intermittent schedule in combination with interferon-alpha2a in pediatric patient...
- Phase I trial and pharmacokinetic study of pyrazoloacridine in children and young adults with refractory cancers.
- Phase II trial of pyrazoloacridine in children with solid tumors: a Pediatric Oncology Group phase II study.
- Plasma and CSF pharmacokinetics of ganciclovir in nonhuman primates.
- Plasma and cerebrospinal fluid pharmacokinetics of gemcitabine after intravenous administration in nonhuman primates.
- The development of camptothecin analogs in childhood cancers.
- Phase I trial of intrathecal liposomal cytarabine in children with neoplastic meningitis.
- Phase 2 clinical trial of intrathecal topotecan in children with refractory leptomeningeal leukemia: a Children's Oncology Group trial (P9962).
- Valacyclovir and acyclovir pharmacokinetics in immunocompromised children.
- MDM2 inhibition sensitizes neuroblastoma to chemotherapy-induced apoptotic cell death.
- A phase I trial of amifostine (WR-2721) and melphalan in children with refractory cancer.
- Plasma and cerebrospinal fluid pharmacokinetics of O6-benzylguanine and analogues in nonhuman primates.
- A phase II trial and pharmacokinetic study of oxaliplatin in children with refractory solid tumors: a Children's Oncology Group study.
- Pharmacokinetics and cerebrospinal fluid penetration of CI-994 (N-acetyldinaline) in the nonhuman primate.
- Cyclin D and cisplatin cytotoxicity in primary neuroblastoma cell lines.
- Pharmacokinetics, cerebrospinal fluid penetration, and metabolism of piroxantrone in the rhesus monkey.
- Phase I study of high-dose piroxantrone with granulocyte colony-stimulating factor.
- Phase II evaluation of topotecan for pediatric central nervous system tumors.
- Plasma and cerebrospinal fluid pharmacokinetics of O6-benzylguanine and time course of peripheral blood mononuclear cell O6-methylguanine-DNA methyltransferase inhibit...
- Phase I/II study of 72-hour infusional paclitaxel and doxorubicin with granulocyte colony-stimulating factor in patients with metastatic breast cancer.
- Pharmacokinetics and cerebrospinal fluid penetration of daunorubicin, idarubicin, and their metabolites in the nonhuman primate model.
- Randomized trial of the cardioprotective agent ICRF-187 in pediatric sarcoma patients treated with doxorubicin.
- Pharmacokinetic evaluation of darbepoetin alfa for the treatment of pediatric patients with chemotherapy-induced anemia.
- Obtaining informed consent for clinical tumor and germline exome sequencing of newly diagnosed childhood cancer patients.
- Phase I crossover study of paclitaxel with r-verapamil in patients with metastatic breast cancer.
- Paclitaxel in doxorubicin-refractory or mitoxantrone-refractory breast cancer: a phase I/II trial of 96-hour infusion.
- Principles of treatment of pediatric solid tumors.
- Decision making in pediatric oncology: who should take the lead? The decisional priority in pediatric oncology model.
- Intrathecal 5-fluorouracil in the rhesus monkey.
- Treatment controversies in medulloblastoma.
- Influence of phenytoin on the disposition of irinotecan: a case report.
- Thioguanine administered as a continuous intravenous infusion to pediatric patients is metabolized to the novel metabolite 8-hydroxy-thioguanine.
- Effect of R-verapamil on the pharmacokinetics of paclitaxel in women with breast cancer.
- Pharmacokinetics of piroxantrone in a phase I trial of piroxantrone and granulocyte-colony stimulating factor.
- Pharmacokinetics of taxol and doxorubicin administered alone and in combination by continuous 72-hour infusion.
- Pharmacokinetics of pyrazoloacridine in the rhesus monkey.
- Intrathecal chemotherapy.
- Cytotoxicity and DNA damage associated with pyrazoloacridine in MCF-7 breast cancer cells.
- Advances in the treatment of meningeal cancers.
- Complications of leukemia.
- Re: Toxicity of intrathecal melphalan.
- Disseminated infection with Mycobacterium gordonae: report of a case and critical review of the literature.
- Status of new anthrapyrazole and pyrazoloacridine derivatives.
- Education and the risk of Alzheimer's disease: findings from the study of dementia in Swedish twins.
- Incidence and prognosis of meningitis due to Haemophilus influenzae, Streptococcus pneumoniae and Neisseria meningitidis in Sweden.
- Heritability for Alzheimer's disease: the study of dementia in Swedish twins.
- Incidence, serogroups and case-fatality rate of invasive meningococcal infections in a Swedish region 1975-1989.
- Juvenile chronic myelogenous leukemia with abnormalities of chromosomes 4 and 5.
- Deficits in controlled processing may predict dementia: a twin study.
- Expression of apoptosis-associated genes by human dermal scar fibroblasts.
- Autocrine transforming growth factor-beta(1) activity and glycosaminoglycan synthesis by human cutaneous scar fibroblasts.
- Incidence, aetiology, and prognosis of acute epiglottitis in children and adults in Sweden.
Schools
University of Pittsburgh Main Campus
Chldns Hospital
National Institute Of Health
Doctors Specialties
- Pediatric Hematology
- Oncology
Accepted Insurances
Awards
- America's Top Doctors
- Top Doctors:SE Texas
- America's Top Doctors for Cancer
Education
-
National Institutes of Health Clinical Center -
University of Pittsburgh Medical Center -
University of Pittsburgh School of Medicine
Hospital
-
Texas Children's Hospital
Helpful Reviews
Similar Doctors
|
|
Dr. Demetrios Petropoulos, MD
 This Doctor is OpenDoctor Recommended.
|